Laboratory Considerations for Clinical Trials
Science:Life Sciences
Tracking patient consent for the use of their samples in clinical trials is essential to both minimize risk of non-compliance and maximizing potential for future use.
In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, explains informed consent for patient samples and the importance of easily tracking consent as samples move through the clinical trial ecosystem.
She describes:
- How consent is or has been documented
- The benefits of electronic consent documentation
- Specific consent attributes, e.g. genetic testing
- Handling consent requirements from different countries or institutions
- Understanding consent for future use, including limitations and expirations
Learn more at https://www.q2labsolutions.com/labmatrix
More Episodes
What is the Role of Digital Pathology in Clinical Trials
2023-11-17
288
2023-11-17
288
Flexible Approaches for Biotech Companies in Clinical Trials
2022-06-22
315
2022-06-22
315
Risk Management for Biotech Companies in Clinical Trials
2022-05-16
248
2022-05-16
248
Managing Sample Data from Vendors
2021-09-14
276
2021-09-14
276
Automation within an ADME Laboratory
2021-08-26
232
2021-08-26
232
Bioanalytical Automation of Samples
2021-07-30
207
2021-07-30
207
Tracking Clinical Trial Samples
2021-07-28
200
2021-07-28
200
Avoiding Canceled Tests in Pediatric Samples
2021-02-02
163
2021-02-02
163
Covid Vaccine Testing
2020-09-15
212
2020-09-15
212
Hybrid Assays for Protein Bioanalysis
2020-07-29
176
2020-07-29
176
High Throughput ADME Testing
2020-07-29
120
2020-07-29
120
Liquid Biopsy Collection in Clinical Development Programs
2020-07-29
163
2020-07-29
163
Get this podcast on your
phone, FREE
